TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Octapharma AB
Closing information (x1000 DKK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
1,687,433
|
1,604,894
|
1,393,258 |
| Financial expenses |
16,581
|
80
|
7,983 |
| Earnings before taxes |
66,034
|
121,196
|
56,386 |
| EBITDA |
196,536
|
256,727
|
208,542 |
| Total assets |
1,804,458
|
1,227,871
|
941,593 |
| Current assets |
896,963
|
446,427
|
297,346 |
| Current liabilities |
293,374
|
254,857
|
240,031 |
| Equity capital |
771,376
|
781,002
|
681,987 |
| - share capital |
16,236
|
16,792
|
16,706 |
| Employees (average) |
989
|
1,065
|
984 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
42.7%
|
63.6%
|
72.4% |
| Turnover per employee |
1,706
|
1,507
|
1,416 |
| Profit as a percentage of turnover |
3.9%
|
7.6%
|
4.0% |
| Return on assets (ROA) |
4.6%
|
9.9%
|
6.8% |
| Current ratio |
305.7%
|
175.2%
|
123.9% |
| Return on equity (ROE) |
8.6%
|
15.5%
|
8.3% |
| Change turnover |
135,623
|
204,460
|
198,396 |
| Change turnover % |
9%
|
15%
|
17% |
| Chg. No. of employees |
-76
|
81
|
102 |
| Chg. No. of employees % |
-7%
|
8%
|
12% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.